SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Astec LifeSciences informs about board meeting

18 Apr 2026 Evaluate

Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), Astec LifeSciences has informed that a Meeting of the Board of Directors of the Company (‘Board’) is scheduled to be held on Monday, 27th April, 2026 to, consider and approve the Standalone and Consolidated Audited Financial Results & Statements of the Company for the Quarter and Financial Year ended March 31, 2026, after these results are reviewed by the Audit Committee. The copy of the intimation is also available on the website of the company at https://www.godrejastec.com.

The above information is a part of company’s filings submitted to BSE.

Astec Lifesciences Share Price

707.35 -19.15 (-2.64%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
UPL 656.15
PI Industries 3036.95
Bayer CropScience 4852.90
Sharda Cropchem 1101.50
Sumitomo Chemical 446.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×